Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2016-08-10

Clinical Trial Update: SL-AF Trial - (Six Lead Identification of Atrial Fibrillation [AF]) [NA]

View source ↗

Summary

The SL-AF trial, evaluating six-lead identification of atrial fibrillation, has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Cardiocity Limited | Conditions: Atrial Fibrillation | NA | Status: COMPLETED